Fundamentals of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)

Oliver Chow*, Marie Jaeger, Sepehr Seyed Lajevardi, Anand K. Deva

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is T-cell CD30+ lymphoma with a significant public health concern for women with breast implants. The epidemiologic picture of BIA-ALCL remains unclear, with increasing incidence rates and still largely underreported. There are 35 million patients with implants in the world and more than 1, 685, 471 breast augmentations are performed annually worldwide, for this reason, it is crucial that every plastic and reconstructive surgeon knows in detail the genetic bases, associated risk factors, clinical features, diagnostic approach and timely treatment of BIA-ALCL. This chapter will attempt to provide a concise overview of BIA-ALCL.

Original languageEnglish
Title of host publicationPlastic and reconstructive surgery fundamentals
Subtitle of host publicationa case-based and comprehensive review
EditorsDaniel De-Luna-Gallardo, Cuahutémoc Marquez-Espriella, Ricardo Cienfuegos-Monroy
Place of PublicationSwitzerland
PublisherSpringer, Springer Nature
Chapter81
Pages785-792
Number of pages8
ISBN (Electronic)9783031618949
ISBN (Print)9783031618932
DOIs
Publication statusPublished - 1 Jan 2024

Fingerprint

Dive into the research topics of 'Fundamentals of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)'. Together they form a unique fingerprint.

Cite this